Who invested in Affini-T Therapeutics?
Affini-T Therapeutics's investors include Alexandria Venture Investments and Catalio Capital Management.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$175Mraised across 1 round since 2022, from 1 source
Affini-T Therapeutics's investors include Alexandria Venture Investments and Catalio Capital Management.
Affini-T Therapeutics has raised $175M across 1 round since 2022.
Affini-T Therapeutics's most recent round was a Venture of $175M in Mar 2022.
Its most recent round, $175M in Mar 2022, is also its largest on record.
Affini-T Therapeutics's first round on record, in Mar 2022, was backed by Alexandria Venture Investments and Catalio Capital Management.
Affini-T Therapeutics's latest named round is a Venture, in Mar 2022.
Affini-T Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.